| Karin Schmidova, MD | |
|
301 Cedar St, Orofino, ID 83544 | |
| (208) 476-4555 | |
| (208) 476-5385 |
| Full Name | Karin Schmidova |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 21 Years |
| Location | 301 Cedar St, Orofino, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295949519 | NPI | - | NPPES |
| 59202254 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | M13299 (Idaho) | Secondary |
| 208600000X | Surgery | 46691 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Marys Hospital And Clinics | Cottonwood, ID | Hospital |
| Clearwater Valley Hospital & Clinics | Orofino, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Mary's Hospital, Inc. | 5092773168 | 16 |
News Archive
Reuters: A new study in the journal Pediatrics suggests that raising Medicaid reimbursement rates could help more children from low-income families receive flu vaccinations. "Although the vaccine itself is provided free of charge to children covered by Medicaid, doctors are only reimbursed for about half the cost of administering it," and are losing money in the process, say researchers.
While a first time kneecap dislocation can usually be treated non-surgically, recurring dislocations often necessitate surgical intervention. MPFL (medial patellofemoral ligament) reconstructions have become a common surgical option and have seen improved outcomes and a high rate of return to sport.
Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.
Black and Hispanic kidney donors are significantly more likely than white donors to develop hypertension, diabetes and chronic kidney disease, according to new Saint Louis University research published in the August 19, 2010 issue of the New England Journal of Medicine.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
› Verified 6 days ago
| Entity Name | Clearwater Valley Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073551396 PECOS PAC ID: 0547173346 Enrollment ID: O20031117000264 |
News Archive
Reuters: A new study in the journal Pediatrics suggests that raising Medicaid reimbursement rates could help more children from low-income families receive flu vaccinations. "Although the vaccine itself is provided free of charge to children covered by Medicaid, doctors are only reimbursed for about half the cost of administering it," and are losing money in the process, say researchers.
While a first time kneecap dislocation can usually be treated non-surgically, recurring dislocations often necessitate surgical intervention. MPFL (medial patellofemoral ligament) reconstructions have become a common surgical option and have seen improved outcomes and a high rate of return to sport.
Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.
Black and Hispanic kidney donors are significantly more likely than white donors to develop hypertension, diabetes and chronic kidney disease, according to new Saint Louis University research published in the August 19, 2010 issue of the New England Journal of Medicine.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
› Verified 6 days ago
| Entity Name | St. Mary's Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841292307 PECOS PAC ID: 5092773168 Enrollment ID: O20050316000814 |
News Archive
Reuters: A new study in the journal Pediatrics suggests that raising Medicaid reimbursement rates could help more children from low-income families receive flu vaccinations. "Although the vaccine itself is provided free of charge to children covered by Medicaid, doctors are only reimbursed for about half the cost of administering it," and are losing money in the process, say researchers.
While a first time kneecap dislocation can usually be treated non-surgically, recurring dislocations often necessitate surgical intervention. MPFL (medial patellofemoral ligament) reconstructions have become a common surgical option and have seen improved outcomes and a high rate of return to sport.
Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.
Black and Hispanic kidney donors are significantly more likely than white donors to develop hypertension, diabetes and chronic kidney disease, according to new Saint Louis University research published in the August 19, 2010 issue of the New England Journal of Medicine.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karin Schmidova, MD 301 Cedar St, Orofino, ID 83544-9029 Ph: (208) 476-4555 | Karin Schmidova, MD 301 Cedar St, Orofino, ID 83544 Ph: (208) 476-4555 |
News Archive
Reuters: A new study in the journal Pediatrics suggests that raising Medicaid reimbursement rates could help more children from low-income families receive flu vaccinations. "Although the vaccine itself is provided free of charge to children covered by Medicaid, doctors are only reimbursed for about half the cost of administering it," and are losing money in the process, say researchers.
While a first time kneecap dislocation can usually be treated non-surgically, recurring dislocations often necessitate surgical intervention. MPFL (medial patellofemoral ligament) reconstructions have become a common surgical option and have seen improved outcomes and a high rate of return to sport.
Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.
Black and Hispanic kidney donors are significantly more likely than white donors to develop hypertension, diabetes and chronic kidney disease, according to new Saint Louis University research published in the August 19, 2010 issue of the New England Journal of Medicine.
Ambrx Inc, and Merck Serono have announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis.
› Verified 6 days ago
Dr. Paul E Smith, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 4042 Eureka Ridge Rd, Orofino, ID 83544 Phone: 208-476-7630 |